Loomis, Sayles & Company
AVNS

Loomis, Sayles & Company’s Avanos Medical AVNS Stock Holding History

Loomis, Sayles & Company’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-237,212
Closed -$6.97M – 657
2020
Q2 		$6.97M Sell
237,212
-23,036
-9% -$667K 0.01% 367
2020
Q1 		$7.01M Buy
260,248
+10,231
+4% +$306K 0.01% 339
2019
Q4 		$8.43M Sell
250,017
-1,809
-0.7% -$65.5K 0.01% 379
2019
Q3 		$9.43M Sell
251,826
-766
-0.3% -$29.2K 0.02% 352
2019
Q2 		$11M Sell
252,592
-17,301
-6% -$740K 0.02% 332
2019
Q1 		$11.5M Sell
269,893
-411
-0.2% -$18.4K 0.02% 323
2018
Q4 		$12.1M Sell
270,304
-19,851
-7% -$1.04M 0.03% 271
2018
Q3 		$19.9M Sell
290,155
-18,840
-6% -$1.21M 0.04% 214
2018
Q2 		$17.7M Sell
308,995
-1,333
-0.4% -$70.4K 0.04% 276
2018
Q1 		$14.3M Buy
310,328
+2,646
+0.9% +$126K 0.03% 335
2017
Q4 		$14.2M Sell
307,682
-25,959
-8% -$1.19M 0.03% 358
2017
Q3 		$15M Sell
333,641
-5,856
-2% -$250K 0.03% 343
2017
Q2 		$13.3M Sell
339,497
-30,766
-8% -$1.16M 0.03% 353
2017
Q1 		$14.1M Sell
370,263
-6,255
-2% -$244K 0.04% 341
2016
Q4 		$13.9M Sell
376,518
-612
-0.2% -$21.9K 0.03% 357
2016
Q3 		$13.1M Sell
377,130
-10,948
-3% -$383K 0.03% 377
2016
Q2 		$12.6M Sell
388,078
-317
-0.1% -$9.71K 0.03% 385
2016
Q1 		$11.2M Sell
388,395
-880
-0.2% -$23.4K 0.03% 404
2015
Q4 		$13M Sell
389,275
-6,866
-2% -$213K 0.04% 379
2015
Q3 		$11.3M Buy
396,141
+186,907
+89% +$6.52M 0.03% 415
2015
Q2 		$8.47M Buy
+209,234
New +$9.39M 0.02% 482

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company's AVNS Position: Q3 2020 in Review

Loomis, Sayles & Company sold out of Avanos Medical (AVNS) in Q3 2020, closing a stake of 237,212 shares — an estimated $6.97M sold.

Loomis, Sayles & Company first reported a position in AVNS in Q2 2015 and held it in 21 quarters. The position peaked at $19.9M in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q3 2020.

  • Loomis, Sayles & Company reported no remaining Avanos Medical position as of Q3 2020 after selling out during the quarter.
  • Loomis, Sayles & Company sold 237,212 Avanos Medical shares in Q3 2020, an estimated $6.97M.
  • Loomis, Sayles & Company first reported a position in Avanos Medical in Q2 2015 and held it in 21 quarters.
  • Loomis, Sayles & Company's Avanos Medical position peaked at $19.9M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2020.

Based on Loomis, Sayles & Company's 13F filing for Q3 2020, filed 12 Nov 2020.